Scavenger receptor (immunology)

Not to be confused with Scavenger receptor (endocrinology).

Scavenger receptors are a group of receptors that recognize modified low-density lipoprotein[1] (LDL) by oxidation or acetylation. This naming is based on a function of cleaning (scavenging): Scavenger receptors widely recognize and take up macromolecules that have a negative charge, like modified LDL.

Function

Scavenger receptors are thought to participate in the removal of many foreign substances and waste materials in the living body by extensive ligand specificity and a variety of receptor molecules.

In atherosclerotic lesions, macrophages that express scavenger receptors on their plasma membrane take up the oxidized LDL deposited in the blood vessel wall aggressively, and develop into foam cells. Likewise, they secrete various inflammatory cytokines and accelerate the development of atherosclerosis.

Types

Scavenger receptors are categorized into classes A, B, and C according to their structural characteristics.

Class A

Scavenger receptors type 1 (SR-A1) and 2 (SR-A2) are trimers with a molecular weight of about 220-250 kDa (the molecular weight of monomeric protein is about 80 kDa). They preferentially bind modified LDL, either acylated (acLDL) or oxidized (oxLDL). They have a collagen-like domain, which is essential for ligand binding.

Members include:

Class B

CD36 and scavenger receptor class BI (SR-BI) are identified as oxidized LDL receptors and classified into class B. Both proteins have two transmembrane domains, and they are concentrated in a specific plasma membrane microdomain, the caveolae.

Members include:

Other

Some receptors that can bind to oxidized LDL have been discovered.

References

  1. Prabhudas M; Bowdish D; Drickamer K; Febbraio M; Herz J; Kobzik L; Krieger M; Loike J; Means TK; Moestrup SK; Post S; Sawamura T; Silverstein S; Wang XY; El Khoury J (2014). "Standardizing scavenger receptor nomenclature". J. Immunol. 192 (5): 1997–2006. doi:10.4049/jimmunol.1490003. PMID 24563502.
  2. Matsumoto A; Naito M; Itakura H; Ikemoto S; Asaoka H; Hayakawa I; Kanamori H; Aburatani H; Takaku F; Suzuki H (1990). "Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions". Proc. Natl. Acad. Sci. U.S.A. 87 (23): 9133–7. doi:10.1073/pnas.87.23.9133. PMC 55118Freely accessible. PMID 2251254.
  3. Rigotti A; Trigatti BL; Penman M; Rayburn H; Herz J; Krieger M (1997). "A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism". Proc. Natl. Acad. Sci. U.S.A. 94 (23): 12610–5. doi:10.1073/pnas.94.23.12610. PMC 25055Freely accessible. PMID 9356497.
  4. Khovidhunkit W (2011). "A genetic variant of the scavenger receptor BI in humans". N. Engl. J. Med. 364 (14): 1375–6; author reply 1376. doi:10.1056/NEJMc1101847#SA1. PMID 21470028.
  5. Kuchibhotla S; Vanegas D; Kennedy DJ; Guy E; Nimako G; Morton RE; Febbraio M (2008). "Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II". Cardiovasc. Res. 78 (1): 185–96. doi:10.1093/cvr/cvm093. PMC 2810680Freely accessible. PMID 18065445.
  6. Mehta JL; Chen J; Hermonat PL; Romeo F; Novelli G (2006). "Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders". Cardiovasc. Res. 69 (1): 36–45. doi:10.1016/j.cardiores.2005.09.006. PMID 16324688.

External links

This article is issued from Wikipedia - version of the 10/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.